Oncology Information Systems Market by Product & Service (Software and Service), Application (Radiation Oncology, Medical Oncology, and Surgical Oncology), and End User (Hospital & Oncology Clinic and Research Center): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
- Published Date: 2020-10-18
- Report ID: 3266
- Pages: 250
-
Format:
Oncology Information Systems Market Overview:
The global oncology information systems market was valued at $2,622 million in 2017, and is estimated to reach $4,569 million by 2025, registering a CAGR of 7.1% from 2018 to 2025. Patient portfolios are managed by software termed as oncology information systems across the healthcare settings, such as clinics, hospitals, and research laboratories. In addition, this software are used to predict treatment outcomes, plan the patients treatment accordingly, and exchange cancer patient information among the overall healthcare organizations. These advantages improve the safety and efficiency of cancer therapy for patients. Oncology information systems help physicians and surgeons to choose the most appropriate therapy to improve the survival rate of the cancer patients. The availability of a variety of cancer therapies, such as chemotherapy and radiation therapy, and presence of huge cancer population base are the major factors that drive the market growth.
The market is expected to witness a moderate growth during the forecast period, owing to the benefits offered by oncology information systems over conventional methods of record keeping and treatment planning. Furthermore, surge in prevalence of cancer and increase in technological advancements, such as incorporation of patient portals, are expected to boost the market growth. Use of oncology information systems to treat rare cancer and further improvements in the technology by use of artificial intelligence are expected to present various opportunities for market expansion. However, dearth of healthcare IT professionals and high costs associated with oncology information systems are expected to hamper the growth of the market.
The global oncology information systems market is segmented based on product & service, application, end user, and region. Based on product & service, it is bifurcated into software and services. The software segment is further divided into patient information systems and treatment planning systems, while the services segment includes consulting/optimization services, implementation services, and maintenance services. The market is studied across applications such as radiation, medical, and surgical oncology. Based on end user, it is classified into hospital & oncology clinic and research center. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Oncology Information Systems Market:
The study provides an in-depth analysis of the global oncology information systems market along with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry from 2017 to 2025 is provided to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally.
Key market players and their strategies are provided to understand the competitive outlook of the market.
Oncology Information Systems Key Market Segments:
By Product & Services
Software
Patient Information System
Treatment Planning System
Service
Consulting/Optimization Service
Implementation Service
Maintenance Service
By Application
Radiation Oncology
Medical Oncology
Surgical Oncology
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Republic of South Africa
Saudi Arabia
Rest of LAMEA
Key Players Profiled
Accuray Incorporated
Bogardus Medical Systems, Inc.
Cerner Corporation
CureMD Corporation
Elekta AB
Flatiron Health, Inc.
Koninklijke Philips N.V.
McKesson Corporation
RaySearch Laboratories AB
Varian Medical Systems, Inc.
The other players in the value chain include (profiles not included in the report) the following:
Charm Health
Siemens Healthcare
Epic Systems Corporation
Bizmatics, Inc.
Cordata Healthcare Innovations
Chapter: 1: INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. Key oncology information systems available in the market
3.5. Market Share Analysis, 2015
3.6. Regulation of oncology information system
3.7. Market dynamics
3.7.1. Drivers
3.7.1.1. Availability of OIS with improved features
3.7.1.2. Increase in prevalence of cancer cases
3.7.1.3. Advantages of OIS over conventional record maintenance practices
3.7.2. Restraints
3.7.2.1. Dearth of healthcare IT professionals
3.7.2.2. High costs associated with OIS systems
3.7.3. Opportunities
3.7.3.1. Untapped potential of emerging markets
3.7.3.2. Use of artificial intelligence (AI) in oncology information systems
Chapter: 4: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Software
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market size and forecast
4.2.4. Market analysis, by country
4.2.4.1. Patient information systems
4.2.5. Market size and forecast
4.2.5.1. Treatment planning systems
4.2.5.1.1. Market size and forecast
4.3. Service
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market size and forecast
4.3.4. Market analysis, by country
4.3.4.1. Consulting/Optimization services
4.3.4.1.1. Market size and forecast
4.3.4.2. Implementation services
4.3.4.2.1. Market size and forecast
4.3.4.3. Post-sale & maintenance services
4.3.4.3.1. Market size and forecast
Chapter: 5: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Radiation Oncology
5.2.1. Market size and forecast
5.3. Medical oncology
5.3.1. Market size and forecast
5.4. Surgical oncology
5.4.1. Market size and forecast
Chapter: 6: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & oncology clinics
6.2.1. Market size and forecast
6.3. Research centers
6.3.1. Market size and forecast
Chapter: 7: ONCOLOGY INFORMATION SYSTEMS MARKET, BY GEOGRAPHY
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America oncology information system market, by country
7.2.2.1. U.S. oncology information system market by products and services
7.2.2.2. U.S oncology information system market by application
7.2.2.3. U.S. oncology information system market by end user
7.2.2.4. Canada oncology information system market by products and services
7.2.2.5. Canada oncology information system market by application
7.2.2.6. Canada oncology information system market by end user
7.2.2.7. Mexico oncology information system market by products and services
7.2.2.8. Mexico oncology information system market by application
7.2.2.9. Mexico oncology information system market by end user
7.2.3. North America oncology information system market, by products and services
7.2.4. North America oncology information system market, by application
7.2.5. North America oncology information system market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe oncology information system market, by country
7.3.2.1. Germany oncology information system market by products and services
7.3.2.2. Germany oncology information system market by application
7.3.2.3. Germany oncology information system market by end user
7.3.2.4. France oncology information system market by products and services
7.3.2.5. France oncology information system market by application
7.3.2.6. France oncology information system market by end user
7.3.2.7. UK oncology information system market by products and services
7.3.2.8. UK oncology information system market by application
7.3.2.9. UK oncology information system market by end user
7.3.2.10. Italy oncology information system market by products and services
7.3.2.11. Italy oncology information system market by application
7.3.2.12. Italy oncology information system market by end user
7.3.2.13. Rest of Europe oncology information system market by products and services
7.3.2.14. Rest of Europe oncology information system market by application
7.3.2.15. Rest of Europe oncology information system market by end user
7.3.3. Europe oncology information system market, by products and services
7.3.4. Europe oncology information system market, by application
7.3.5. Europe oncology information system market, by end user
7.4. Asia-pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific oncology information system market, by country
7.4.2.1. Japan oncology information system market by products and services
7.4.2.2. Japan oncology information system market by application
7.4.2.3. Japan oncology information system market by end user
7.4.2.4. China oncology information system market by products and services
7.4.2.5. China oncology information system market by application
7.4.2.6. China oncology information system market by end user
7.4.2.7. Australia oncology information system market by products and services
7.4.2.8. Australia oncology information system market by application
7.4.2.9. Australia oncology information system market by end user
7.4.2.10. India oncology information system market by products and services
7.4.2.11. India oncology information system market by application
7.4.2.12. India oncology information system market by end user
7.4.2.13. Rest of Asia-Pacific oncology information system market by products and services
7.4.2.14. Rest of Asia-Pacific oncology information system market by application
7.4.2.15. Rest of Asia-Pacific oncology information system market by end user
7.4.3. Asia-Pacific oncology information system market, by products and services
7.4.4. Asia-Pacific oncology information system market, by application
7.4.5. Asia-Pacific oncology information system market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA oncology information system market, by country
7.5.2.1. Brazil oncology information system market by products and services
7.5.2.2. Brazil oncology information system market by application
7.5.2.3. Brazil oncology information system market by end user
7.5.2.4. Turkey oncology information system market by products and services
7.5.2.5. Turkey oncology information system market by application
7.5.2.6. Turkey oncology information system market by end user
7.5.2.7. Saudi Arabia oncology information system market by products and services
7.5.2.8. Saudi Arabia oncology information system market by application
7.5.2.9. Saudi Arabia oncology information system market by end user
7.5.2.10. South Africa oncology information system market by products and services
7.5.2.11. South Africa oncology information system market by application
7.5.2.12. South Africa oncology information system market by end user
7.5.2.13. Rest of LAMEA oncology information system market by products and services
7.5.2.14. Rest of LAMEA oncology information system market by application
7.5.2.15. Rest of LAMEA oncology information system market by end user
7.5.3. LAMEA oncology information system market, by products and services
7.5.4. LAMEA oncology information system market, by application
7.5.5. LAMEA oncology information system market, by end user
Chapter: 8: COMPANY PROFILES
8.1. Accuray INCORPORATED
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. Bogardus Medical Systems, Inc.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.3. Cerner Corporation
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. CureMD Corporation
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Key strategic moves and developments
8.5. Elekta AB
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Flatiron Health, Inc.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments
8.7. Koninklijke Philips N.V. (PHILIPS HEALTHCARE)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. McKesson Corporation
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. RaySearch Laboratories AB
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.10. VARIAN MEDICAL SYSTEMS, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
